Latest Breaking News On - Connie matsui - Page 2 : comparemela.com

Balboa Park groups merge ahead of Botanical Building repairs

Print Two well-known Balboa Park groups have officially tied the knot and are celebrating their union with a new name: Forever Balboa Park. Thursday, the nonprofits previously known as the Balboa Park Conservancy and the Friends of Balboa Park, announced the all-new, singular identity following a merger that went into effect on July 1. The name Forever Balboa Park, workshopped by a local branding agency, is meant to convey the legacy of one of San Diego’s greatest assets. A new logo and branding materials are still the works. “Adopting a new name demonstrates our own willingness to embrace change as well as our belief in becoming an even stronger partner to all who value Balboa Park and want to help sustain and support it,” Connie Matsui, who co-chairs the board, said in a statement. “As the new name implies, we honor the comprehensive vision of the park’s founders while encouraging ongoing innovations and improvements that will enhance the park’s vitality and rich di

Mayor Todd Gloria Appoints 15 San Diegans To Asian-Pacific Islander Advisory Group

Mayor Todd Gloria announced Tuesday the formation of his administration's Asian-Pacific Islander Advisory Group and the selection of 15 San Diegans who will.

Sutro Biopharma Promotes Trevor Hallam, Ph.D., to President of Research and Chief Scientific Officer

Share this article Share this article SOUTH SAN FRANCISCO, Calif., April 20, 2021 /PRNewswire/  Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and autoimmune therapeutics, today announced the promotion of Chief Scientific Officer Trevor Hallam, Ph.D., to President of Research. Dr. Hallam will also continue his role as Chief Scientific Officer. Since joining Sutro as CSO more than 10 years ago, Trevor has been instrumental in the development of our cell-free protein synthesis platform from a novel but immature technology to a robust multi-modality platform with a proven manufacturing capability. Additionally, Trevor conceived of and drove our vision to initially focus the platform on antibody drug conjugates (ADCs). Using Sutro s platform for ADCs captures the advantages and power of our proprietary cell-fre

Balboa Park shakeup: Two nonprofits to become one city partner

Artelo Biosciences Appoints Finance and Healthcare Industry Executive Tamara A. Seymour to Board of Directors